| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 9.214 | 27.194 | 43.344 | 76.701 |
| Total Income - EUR | - | - | - | - | - | - | 9.214 | 27.194 | 43.344 | 76.701 |
| Total Expenses - EUR | - | - | - | - | - | - | 8 | 920 | 11.692 | 44.417 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 9.206 | 26.275 | 31.652 | 32.285 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 8.929 | 25.590 | 31.282 | 30.029 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Ziranmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 1.142 | 1.200 | 17.466 |
| Current Assets | - | - | - | - | - | - | 9.246 | 24.927 | 30.901 | 28.846 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 3.136 |
| Receivables | - | - | - | - | - | - | 2.093 | 20.782 | 23.391 | 25.575 |
| Cash | - | - | - | - | - | - | 7.153 | 4.145 | 7.510 | 135 |
| Shareholders Funds | - | - | - | - | - | - | 8.970 | 25.638 | 31.381 | 30.128 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 277 | 432 | 719 | 16.185 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ziranmed S.r.l.